Trade with Eva: Analytics in action >>
Showing posts with label ACRS. Show all posts
Showing posts with label ACRS. Show all posts

Wednesday, September 20, 2023

Unusual Options Activity Wed 9/20/23

Stocks seeing volatility buying (bullish call buying/bearish put buying):


Calls:

  • TVTX Oct 15 calls are seeing interest with 140 contracts trading vs. open int of 790, pushing implied vol up around 38 points to ~247.84%. The Co is expected to report its next earnings in late October/early November
  • DYN Dec 7.50 calls are seeing interest with 80 contracts trading vs. open int of 1660, pushing implied vol up around 11 points to ~149.04%

Puts:

  • ACRS Dec 7.50 puts are active with 320 contracts trading vs. open int of 2100, pushing implied vol down around 78 points to ~397.77%. The Co announced results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor on Monday
  • AKRO Nov 45 puts are active with 230 contracts trading vs. open int of 3150, pushing implied vol down around 13 points to ~166.85%

Sentiment: The CBOE Put/Call ratio is currently: 0.92, VIX: (14.17, +0.06, +0.43%).
October 20 is options expiration -- the last day to trade October equity options.

Tuesday, September 19, 2023

Unusual Options Activity Tue 9/19/23

Stocks seeing volatility buying (bullish call buying/bearish put buying):

Calls:

  • LCID Jan 85 calls are seeing interest with 170 contracts trading vs. open int of 9890, pushing implied vol up around 39 points to ~172.74%. The Co is expected to report its next earnings in November
  • TVTX Oct 20 calls are seeing interest with 40 contracts trading vs. open int of 590, pushing implied vol up around 16 points to ~171.31%. The Co is expected to report its next earnings in late October/early November

Puts:

  • ACRS Dec 7.5 puts are active with 260 contracts trading vs. open int of 1790, pushing implied vol down around 76 points to ~324.41%. The Co announced results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor yesterday
  • SRPT Nov 75 puts are active with 130 contracts trading vs. open int of 1860, pushing implied vol down around 14 points to ~145.24%. The Co is expected to report its next earnings in late October/early November

Sentiment: The CBOE Put/Call ratio is currently: 0.91, VIX: (14.23, +0.23, +1.64%).
October 20 is options expiration -- the last day to trade October equity options.